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(TU). CHT efficacy were estimated as follows: progression (grade I) – 
increase of area and/or intensity of TU; stabilization (II) – unchanged 
image of BC; partial effect (III) – intermediate (30-70%) decrease in 
intensity and area of TU in BC; prominent efficacy (IV) – only small 
foci of low residual TU in BC; complete resolution (V) – TU in BC on 
the level of background. 
Results: BS detected complete resolution of TU in primary tumor in 10 
(20%) of 50 treated pts, in additional 12 (24%) cases efficacy of CHT 
was prominent, 15 (30%) women had scintigraphic sings of 
stabilization or progression of BC. 
Number of CHT cycles significantly influence character of BS changes. 
After 2 cycles of TAC ± trastuzumab 2 of 10 patients demonstrated 
sings of grade IV, one – of grade III tumor response and other 7- 
stabilization or progression of BC. 
After 3 cycles 7 (44%) of 16 women had good (grade IV-V) efficacy of 
CHT, in other 9 (56%) cases scintigraphic response was moderate or 
poor (grade I-III). 
After 4-6 CHT cycles TU uptake in primary tumor disappeared (V) or 
become markedly reduced (IV) in 13 (54%) of 24 patients. In 6 (25%) 
women BS data reflect non-significant efficacy of CHT. 
Conclusions: BS performed after 4-6 cycles of TAC ± trastuzumab CHT 
indicate that more than a half (56%) of women with advanced BC 
become the candidates for breast irradiation instead of mastectomy.  
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Purpose/Objective: 1) To compare mean heart and left anterior 
descending coronary artery (LAD) doses from left breast radiotherapy 
(RT) delivered using different fractionation schedules and techniques 
(free breathing (FB) versus activated breathing controlled deep 
inspiratory breath-hold (ABC_DIBH).  
2) To define a useable surrogate variable for mean heart and LAD dose 
in order to facilitate plan comparison. 
Materials and Methods: Sixteen patients whose hearts were within 
tangents based on radiotherapy planning CT scans in FB were 
subsequently scanned in ABC_DIBH. Heart, LAD, whole breast/chest 
wall and partial breast clinical target volumes were outlined 
retrospectively. Plans were prepared for each patient and for both 
techniques according to ICRU 62 criteria. DVH data for three different 
fractionation schedules (50Gy/25#, 40Gy/15# and 27Gy/5#) were used 
to determine heart and LAD *NTDmean and NTDmean per fraction as well 
as the volume of heart receiving 25% of the prescribed dose (heart 
V25%) (*NTDmean is a biologically weighted mean of total dose to tissue 
normalised to 2Gy fractions using a standard linear quadratic model). 
In addition the maximum heart depth (MHD) was measured. The 
correlation between heart NTDmean/NTDmean per fraction and both 
heart V25% and MHD was assessed.  
Results: For 27Gy/5#, 40Gy/15# and 50Gy/25# plans respectively, 
mean heart NTDmean for FB plans was 2.7, 3.1 and 3.5Gy (p<0.001) and 
for ABC 0.7, 0.9 and 1.1Gy (p<0.001). Mean LAD NTDmean for FB plans 
was 19.4, 20.1 and 22.6Gy (p<0.001) and for ABC 5.7, 6.4, 7.4Gy 
(p<0.001). Mean heart NTDmean per fraction for FB plans was 0.55, 0.20 
and 0.14Gy (p<0.001) and for ABC 0.14, 0.06 and 0.04Gy (p<0.001). 
Mean LAD NTDmean per fraction for FB plans was 3.88, 1.35 and 0.90Gy 
(p<0.001) and for ABC 1.15, 0.43and 0.30Gy (p<0.001). Linear 
correlation r2 values of0.98 and 0.72 were obtained for the correlation 
between heart NTDmean/heartNTDmean per fraction and heart V25% and 
MHD respectively. 
Conclusions: Heart and LAD NTDmean decrease with the increasingly 
hypofractionated schedules assessed here. In contrast, heart and LAD 
NTDmean per fraction increase with increasingly hypofractionated 
schedules. Heart V25% is a useful and easily derived surrogate for heart 
NTDmean/NTDmean per fraction. 
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Purpose/Objective: To report the 4-year results of accelerated 
partial breast irradiation (APBI) by means of three-dimensional 
conformal radiotherapy (3D-CRT) following breast-conserving surgery 
(BCS) for early-stage breast cancer. 
Materials and Methods: Between 2006 and 2010, in 44 cases of low-
risk, pT1-2 (≤30 mm) pN0 M0 breast cancer, postoperative APBI was 
given by means of 3D-CRT using 3 to 5 non-coplanar fields. The total 
dose of APBI was 36.9 Gy (9 x 4.1 Gy) using a twice-a-day 
fractionation over 5 consecutive days. Four-year survival results, early 
and late toxicities, and cosmetic results were analyzed. 
Results: At a mean follow-up of 47.5 months neither loco-regional nor 
distant failure was observed. No patient died of breast cancer, but 
two of them died of internal disease. The 4-year probability of overall 
survival was 93.3%. Grade 2 or worse acute side-effect was not 
observed. Data on late toxicities and cosmetic results were available 
in 43 cases (97.7%). Grade 1, 2, and 3 fibrosis occurred in 22 (51.2%), 
7 (16.3%), and 1 (2.3%) patients, respectively. Only 4 patients (9.3%) 
developed slight (grade 1) skin hyperpigmentation. No patient 
developed grade 2-4 late skin side effect. Asymptomatic fat necrosis 
was detected in 8 cases (18.6%) on follow-up mammography. 
Excellent, good, fair, and poor cosmetic outcome was reported in 12 
(27.9%), 23 (53.5%), 8 (18.6%), and 0 (0%) patients, respectively. 
Conclusions: 3D-CRT is a feasible technique for the delivery of APBI 
following conservative surgery for the treatment of low-risk, early-
stage invasive breast carcinoma. Four-year results are promising, 
early- and mid-term radiation side effects are rare, and cosmetic 
results are excellent. 
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Purpose/Objective: Different breath movement management 
techniques have been described which effectively spare the heart in 
tangential breast irradiation. The most easy and cheapest way is 
voluntary moderately Deep Inspiration Breath Hold (vmDIBH), but 
reproducibility, and thus actual dose delivery, of this method is 
unclear. The aim of this study is to determine whether the 2D 
measured delivered transit dose is comparable for vmDIBH and free 
breathing (FB) breast irradiations.  
Materials and Methods: Data of 11 patients irradiated during vmDIBH 
and 9 patients irradiated in FB were analyzed. Patients were 
irradiated using a forward IMRT technique to a total dose of 42.7 or 50 
Gy in 16 or 25 fractions,respectively. A Shrinking Action Level (SAL) 
protocol was used for set-up verification using α=10 mm and nmax=3. 
2D transit portal dosimetry was performed for the tangential fields on 
various days, resulting in 386 and 156 measurements for the vmDIBH 
and FB patients, respectively. The delivered transit dose was 
compared to a predicted dose by calculating global gamma values 
with gamma criteria of 3% and 3 mm. The percentage of pixels with an 
absolute gamma value>1 (γ>1) was determined for each measured 
fraction, for both latero-medial and medio-lateral beams. Mean values 
of this parameter were compared between the vmDIBH and FB patient 
groups. Gamma images with more than 5% of the pixels >1 were 
classified as 'failed'. To find an explanation for these failures, these 
gamma images were evaluated visually. If an image showed isolated 
regions of both underdosage and overdosage, gamma and hence dose 
differences were considered to be due to a simple translation 
(residual set-up error or organ motion); if a gamma image showed 
other patterns, dose differences were considered to be due to 
rotation or deformation of the breast.  
Results: The |γ|>1 for all patients was on average 22.0%±10.9% (1 
SD). For the vmDIBH and FB patients, these values were 22.3±11.1% 
and 21.3%±10.5% (1 SD), respectively. No significant difference was 
found (p>0.05). 76% of the gamma images were classified as 'failed', 
77% in vmDIBH patients and 73% in FB patients. In both groups, 24% of 
the 'failures' was attributed to translations. The |γ|>1was 24.4±11.0% 
and 20.2±9.9% (1 SD) for the medio-lateral fields, respectively 
(p>0.05). For the latero-medial fields, these numbers were 22.7±10.8% 
and 24.5± 12.1% (1 SD), respectively (p>0.05) (Figure 1). 
